Atlas Trials

Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease

Clinical trial NCT07262476 · RECRUITING

Trial details

NCT number
NCT07262476
Sponsor
Minghui Pharmaceutical (Hangzhou) Ltd
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Thyroid Eye Disease (TED)
Start date
2026-01-09
Primary completion
2029-01-31
Enrollment
258

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.